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ABSTRACT
This study investigated the adjuvant effect of Boesenbergia pandurata (BP), Zingiber zerumbet (ZZ), Solanum 
ferox (SF) on protection of tilapia with injection Pseudomonas sp. (Pseumulvacc) vaccination. The extract 
concentrations of BP (600 mg/L), ZZ (200 mg/L), and SF (900 mg/L) were combined with the vaccine, ratio 
between vaccine and extract was 1:1. Tilapia fish were injected with vaccine mix the extract and challenged at day 
7 (d7), 14 (d14), and 21 (d21) post vaccination through injection with A. hydrophila and P. fluorescens (105 CFU/
mL each bacteria). The results shown that the fish with BP+V were found in fin rot at d14 days challenge.  The 
same symptom was found in ZZ+V at d14 challenge as much 11.11% and 42.86% while, in the vaccine groups 
(V), after the challenge, tilapia were found fin rot and darkness color until the last experiment. The BP+V and 
SF+ZZ+V groups shown reducing the number of bacteria in the fish body after challenge test on d7, d14, and 
d21. The efficacy of Pseumulvacc vaccine has increased after its administration with BP (BP+V) on day 7 and day 
14 after challenge (90%) and 100% at the time of challenge test d21. The conclusion is B. pandurata extract was 
a promising adjuvant candidate, and the extract is the best plants as an adjuvant that mixed with the vaccine to 
against A. hydrophila and P. fluorescens infection.
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ABSTRAK
Penelitian ini bertujuan mengevaluasi efek adjuvan dari ekstrak tanaman temu kunci (Boesenbergia pandurata/
BP), lempuyang (Zingiber zerumbet/ZZ), dan terung asam (Solanum ferox/SF) pada ikan nila yang diberikan 
bersama vaksin bakteri Pseudomonas sp. (Pseumulvacc). Dosis yang digunakan yaitu ekstrak BP 600 mg/L, ZZ 
200 mg/L, dan SF 900 mg/L, dengan rasio antara vaksin dan ekstrak 1:1. Pengujian diawali dengan menginjeksi 
ikan nila dengan campuran vaksin dan ekstrak tanaman, dilanjutkan dengan uji tantang pada hari 7 (d7), 14 (d14) 
dan 21 (d21) pascavaksinasi dengan bakteri A. hydrophila dan P. fluorescens (kepadatan masing-masing 105 CFU/
mL). Hasil pengujian menunjukkan ikan yang divaksin dengan penambahan ekstrak BP (BP+V) mengalami sirip 
gripis pada uji tantang hari ke-14, gejala serupa juga ditemukan pada pemberian vaksin yang dicampur dengan 
ZZ (ZZ+V) pada waktu uji tantang d14, sebesar 11,11 % dan 42,86%. Sedangkan, yang divaksin tanpa campuran 
ekstrak (V) mengalami sirip gripis dan menghitam pada uji tantang d14. Perlakuan BP+V dan SF+ZZ+V mampu 
mengurangi jumlah bakteri di dalam tubuh ikan nila pasca uji tantang d7, d14 dan d21, dan jumlahnya lebih rendah 
dibandingkan dengan perlakuan lain. Efikasi vaksin Pseumulvacc mengalami peningkatan pada BP+V pada hari 7 
dan hari 14 pasca ujitantang (90%) dan 100% pada waktu uji tantang d21. Semakin lama uji tantang (d21), tingkat 
perlindungan vaksin plus ekstrak makin tinggi dibandingkan dengan hari d7 dan d14. Ekstrak B. pandurata adalah 
tanaman terbaik sebagai adjuvan untuk penanggulangan infeksi bakteri A. hydrophila dan P. fluorescens.
Kata kunci: Adjuvan, ekstrak tanaman, vaksin, patogen pada ikan 
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INTRODUCTION
The cultivation of tilapia grows rapidly, 
followed by the used for its rich source of protein 
(Wang et al., 2016), excellent gelatin source taken 
from the bone (Alfaro et al., 2013), or skin and 
scales (Jamilah & Harvinder, 2002). It triggers 
the increase of intensive aquaculture production, 
which leads to the increasing number of mortality 
caused by pathogens, disruption of cultivated land 
sustainability, and the slowing growth (Kibenge et 
al., 2012).
Vaccination is a more environmental friendly 
in pathogen prevention technology compared 
to the application of antibiotics and other drugs 
(Sommerset et al., 2005; Rodger, 2016; Sukenda 
et al., 2018). In general, there are three methods 
for immunostimulant or vaccine application 
in fish include injection, immersion, and feed. 
Pasnik et al. (2005); Hardi et al. (2013); and 
Evensen (2016) stated that vaccination through 
intraperitoneal injection (IP) has a better efficacy 
rate than two other methods.
Giving the vaccine in combination with oil-
based adjuvants would potentially improve vaccine 
efficacy in fish. Some of the adjuvant materials 
used in fish include Freund’s adjuvants used with 
fish vaccine (Bøgwald & Dalmo, 2012; Dalmo et 
al., 2016), EseD a Putative T3SS (Edwardsiella 
tarda has a type III secretion system) (Wang 
et al., 2010; Jiao et al., 2010b); Streptococcus 
agalactiae and Aeromonas hydrophila (Pasaribu 
et al., 2018). In addition, the use of other adjuvant 
mineral oils reported being effective in increasing 
the performance of Moritella viscosa vaccine and 
Aeromonas salmonicida in salmon (Mutoloki et 
al., 2010). Furthermore, non-oil material which 
also acts as adjuvant is aluminum salts (Jiao et 
al., 2010a), β-Glucans (Dalmo & Bøgwald, 
2008; Mizel & Bates 2010); plant extract 
Quillaja saponaria saponin (Wang et al., 2016); 
a combination of Ocimum sanctum plant extract 
(Tulsi), Withania somnifera (Ashwagandha), 
Tinospora cordifolia (Guduchi), and Emblica 
offcianaliss  (Amlaki) (Priyadarshini et al., 2012).
Saponin is steroids and terpenoid glycosides 
produced by several species of plants (Song, 
2009; Sun et al., 2009; Tafalla et al., 2013) and 
could serve as specific adjuvants (Dalmo et 
al., 2016). This material has immunostimulant 
capabilities for animals including fish; is able to 
increase macrophage cell phagocytosis activity, 
antibody production, and produce cytotoxic 
T-lymphocytes (CTLs) which can inhibit 
exogenous antigen (Zhang et al., 2007; Xie et al., 
2008; Tam & Roner, 2011;). According to Freitas 
et al. (2006) and Wang et al. (2016), the saponins 
from the Q. saponaria plant are non-toxic and 
capable of enhancing the specific immune system 
and tend to be immune protective in mixing 
with the Leishmania donovani vaccine. Saponin 
testing as an adjuvant has also been performed 
by Wang et al. (2016), the result indicated that 
the Vibrio anguillarum vaccine combined with 
Q. saponaria could enhance humoral antibody 
responses and increases the protective level 
of turbot (Scophthalmus maximus) fish after 
bacterial infection. 
The Borneo plant extract of Boesenbergia 
pandurata (BP), Solanum ferox (SF), and Zingiber 
zerumbet (ZZ) are plants which easily grown in 
the yard and used as herbs plants by communities 
in east Kalimantan (Borneo). Based on previous 
research, that plant extracts containing saponins 
could serve as immunostimulants for tilapia 
(Hardi et al., 2016a,b and Hardi et al., 2017a,b). 
This study aimed to obtain information and test 
the associated potential adjuvant of B. pandurata 
extract, S. ferox, and Z. zerumbet in improving the 
efficacy of Pseumulvacc vaccine in tilapia.
MATERIALS AND METHODS
Experimental fish
The experimental fish sized about 15 g was 
tilapia originated from Seed Fishery Seedling 
Center Sebulu, Kutai Kartanegara District, 
which previously quarantined and isolated to 
ensure A. hydrohila and P. fluorescens free. The 
experimental fish was checked with A. hydrophila 
and P. fluorescens through isolating the gill and 
kidney in GSP media then incubated at 30°C for 
18‒21 hours. If the bacteria was not growth, the 
fish was ready to be used for this study, otherwise, 
if the bacteria was growth, the fish was immersed 
with formaline solutions 3% for five minutes 
(Kent et al., 2009).
Plant material extraction
Boesenbergia pandurata, Z. zerumbet, 
and S. ferox herbal materials were collected 
from the traditional market in Samarinda. The 
extraction process carried out using Limsuwan 
and Voravuthikunchai et al. (2008) and Hardi et 
al. (2016a) methods. The first step in extraction 
methods was cutting the plants into smaller 
pieces, oven-dried for four days or until dry and 
the air-dried plant samples were mashed using a 
blender. The dried samples were soaked in ethanol 
(96%) at room temperature with the ratio 1:1 for 
160 Esti Handayani Hardi et al. / Jurnal Akuakultur Indonesia 17 (2), 158–167 (2018)
48 hours. The extract solution was filtered with 
Whatman® filtration paper and the filtered sample 
was centrifuged for 24 hours at 50 rpm to obtain a 
crude extract. The last step was to keep the crude 
extract in the oven (30‒40oC) until the ethanol 
lost from the extract, then the extract were kept 
in the refrigerator at -4oC until used. The extract 
concentrations used were 600 mg/L B. pandurata, 
900 mg/L S. ferox and 200 mg/L Z. zerumbet (Sun 
et al., 2016a,b and Hardi et al., 2017a,b). The 
dose was achieved by diluting it using a sterile 
distilled water.
Bacteria test
Aeromonas hydrophila (EA-01) and P. 
fluorescens (EP-01) used as a bacterial test 
challenge, and Pseudomonas sp. as a bacterial 
vaccine came from the Microbiology Laboratory, 
Faculty of Fisheries and Marine Science, 
Mulawarman University, Indonesia. Bacteria 
were grown in the media brain heart infusion 
broth (BHIB DIFCO®) and brain heart infusion 
agar (BHIA, DIFCO®) for 24 hours at 30oC.
The vaccine (Pseumulvacc) for Pseudomonas 
sp. bacteria was produced by inactivating using 
3% formalin for 24 hours. The density of bacteria 
vaccine used was 104 CFU / mL (Hardi et al., 
2014b).
The bacteria for the challenge test used were a 
combination of A. hydrophila and P. fluorescens 
1:1 ratio with the density of each bacterium 105 
CFU/mL (Hardi et al., 2017a). The administration 
was intramuscularly injected of 0.1 mL/fish 
(Hardi et al., 2014a).
Effectiveness test of B. pandurata, S. ferox, and 
Z. zerumbet as an adjuvant of Pseumulvacc 
vaccine
Experiment test was conducted by mixing each 
extract with a vaccine ratio 1:1. This experiment 
consisted of 6 groups: (1) extract of B. pandurata 
mix with vaccine (BP + V); (2) Solanum ferox 
extract mix with vaccine (SF + V); (3) Zingiber 
zerumbet extract mix with vaccine (ZZ + V); (4) 
concoction S. ferox and Z. zerumbet mix with 
vaccine (SF + ZZ + V); (5) Vaccine without extract 
(V); (6) control group. This extract that using as 
an adjuvant in this research based on the pre-
research, the concoction S. ferox, and Z. zerumbet 
was the best extract as an immunomodulatory 
extract than other concoction (B. pandurata and 
S. ferox or B. pandurata and Z. zerumbet).
Vaccine plus extract was injected to fish by 
intraperitoneal injection as many of 0.1 mL/fish. 
Challenge test was conducted on days 7, 14, and 
21 post vaccination. The observations parameters 
were the percentage of fish undergoing changes 
in the anatomy of the external organs and internal 
organs, the total number of bacteria in the body of 
the tilapia fish, the total leucocyte, antibody titers, 
phagocytic index, and cumulative of mortality 
and RPS (relative percent survival).
Fish pathology anatomy
This parameter was done to evaluate the 
percentage of fish pathology anatomy post 
vaccination and challenge test. The observed fish 
pathology anatomy were fin rot, body darkness, 
and exophthalmia. The percentage of fish 
pathology anatomy was calculated according to 
Hardi et al. (2017 a,b) formula.
Total bacteria
Record the results for the total bacteria in 
the fish body after challenges test, calculate the 
mean colony count of five sample. As much 1 g 
of sample organ was crushed, then put into 9 ml 
of sterile distilled water and continued by dilution 
7, 8, 9, and 1 ml of suspense were grown on TSA 
agar medium, incubated at 30°C for 24 hours. 
The number of bacterial cells is calculated using 
colony number as Hardi et al. (2016a):
Note:
N : The total colony number, (CFU/gram of
   dry mass
n : The mean colony count of five sample
   plates
F : The dilution factor
M : The weight of the test portion (gram)
X : The dry matter content of the sample 
(%)
Total leucocyte
Total leucocyte describes the number of 
leucocyte cells in the fish body after vaccine and 
challenge test with pathogenic bacteria (Blaxhall, 
1972). The first step of total leucocyte examination 
has collected the blood from the fish, put into 
microtube and then the blood sample was sucked 
with a leucocyte pipette up to 0.5 and added Turk’s 
solution into 11 scales, wiggling the pipette to 
% Fish pathology 
anatomy
Fish pathology anatomy 
Alive fish in the end of 
treatment
= × 100
N =
n × 300 × f
× 100
m × X
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homogeneously. Remove the first droplet, the next 
inserted the blood mix Turk’s solution into the 
hemocytometer and cover with a cover glass, put 
on the microscope and accounted the cells. The 
number of leucocyte cells calculated on the five 
large boxes of hemocytometer and calculation by 
using the formula:
Total leucocyte = ∑ leucocyte cells × 50 cell/
mm3
Antibody titers
Serum preparation: fish blood was collected 
via caudal veins and put it in a micro tube, the 
next step was centrifuged at 3000 rpm for 3 
minutes. After the serum was separated from the 
blood cells, incubated at 44°C for 20 minutes to 
activate the complement (Lumsden et al., 1993). 
The serum was stored in a refrigerator at 4°C for 
antibody titer observation.
The antibody titers measurements were 
carried out by taking 25 µL of PBS solution and 
inserted into the microplate at holes 1st through 
12th, then inserting 25 µL blood serum at 1st hole 
and diluting the level up to 11th hole. As much as 
25 µL of bacteria inserted into 1st hole to 12th, then 
the microplate homogenized by gently waving. 
Further, it stored for two hours in the incubator 
at 37°C, followed by storing into the overnight 
in refrigerator 4°C, the antibody titers were 
determined from the last remaining hole of the 
agglutination reaction. 
Phagocytic index
Phagocytic index was measured using 
Anderson and Siwicki (1995) method as much 50 
μL of blood put into the microtube, added 50 μL 
of a Staphylococcus aqueous suspension in PBS 
(107 cells/mL) was homogenized and incubated at 
room temperature for 20 min. Make a prepared 
on the glass object and dry it out. Next step was 
fixing with methanol for five minutes and air-
dried, stained by immersion into Giemsa for 15 
minutes, washed with running water and dried 
with tissue, and then observed and counted the 
number of cells showing the phagocytic process 
of 100 phagocyte cells observed.
Cumulative mortality & RPS
The effectiveness of the extract as an adjuvant 
vaccine was measured by observing the fish 
mortality after challenges with A. hydrophila and 
P. fluorescens. Cumulative of mortality and RPS 
method using Ellis (1988) method. 
Data analysis
All results were presented in the average 
and standard deviation of three independent 
measurements. Cumulative mortality and RPS 
were analyzed using nonparametric ANOVA 
(SPSS 16 computer program) was used to 
determine whether there was a significant 
difference (P<0.05) compared to control and 
vaccine groups, while the hematological and 
immunological parameters were analyzed with 
description.
RESULTS AND DISCUSSION
Results
Fish pathology anatomy 
Bacterial infections of A. hydrophila and 
Pseudomonas sp. causing exophthalmia symp-
toms in the eyes, fin rots and bleeding (Hardi et 
al., 2014a). The test results show that prevention 
of bacterial infection of A. hydrophila and P. fluo-
rescens using vaccine mixed with plant extract 
reducing the fish symptoms such as fin rot, dark-
ness and exophthalmia average decreased on day 
14 post-challenge, and the results for all treatment 
were significantly different from vaccine without 
extract (P< 0.05) on test challenges d21 (Table 1).
Total bacteria in tilapia after the challenge test
The number of bacteria in the fish body also 
decreased in the vaccinated without and mixed 
with the plant extract on day 14 after the chal-
lenge test. The highest decrease was found in the 
treatment of SF+ ZZ+V  reached 103 CFU / mL 
and the result was significantly different from the 
un extracted vaccine (V) (P< 0.05).
Total leucocytes
Post vaccination leucocyte types also in-
creased, either with extracts or with no extracts. 
The increase in total leucocytes occurred from 
day 7 to day 21 after vaccination, and the highest 
increase occurred in indigo fish injected with a 
vaccine with a mixture of S. ferox and Z. zerumbet 
(Table 3).
Increased leucocytes occurred along with the 
formation of antibodies in fish after 5‒10 days 
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Table 3. Total leukocytes at post-vaccination observation in day 14th after post challenge with bacteria A. hy-
drophila and P. fluorescens
Group
Challenges time (105 cells/mm3)
Day-7 Day-14 Day-21
BP + V* 3.4 ± 0.05 4.5 ± 0.04 4.6 ± 0.02
SF + V* 2.9 ± 0.07 4.3 ± 0.05 4.4 ± 0.03
ZZ + V* 3.6 ± 0.1 3.9 ± 0.059 4 ± 0.05
ZZ+SF + V* 3.8 ± 0.06 4.9 ± 0.05 5 ± 0.05
V* 3.0 ± 0.04 4.0 ± 0.04 4.1 ± 0.05
Control 1.6 ± 0.05 1.8 ± 0.05 1.8 ± 0.03
Note: BP (Boesenbergia pandurata), SF (Solanum ferox), ZZ (Zingiber zerumbet), and V (Vaccine Pseumulvacc)
Table 1. The anatomical pathology of the outer organ of tilapia observation in day 14th after post challenge test with 
bacteria A. hydrophila and P. fluorescens
Group Pathology anatomy (%)
Challenges time
 d7 d14  d21
BP+V*
Fit rot 0.00 ± 0.5 11.11 ± 0.5 0.00
Darkness 20 ± 0.5 0 0
Exophthalmia 0 0 0
SF+V*
Fit rot 16.67 ± 0.5 0 0
Darkness 0 0 0
Exophthalmia 0 0 0
ZZ+V*
Fit rot 28.57 ± 0.5 42.86 ± 0.5 0
Darkness 0 0 10 ± 0.5
Exophthalmia 0 0 0
SF+ZZ+V*
Fit rot 0 60 ± 0.5 40 ± 0.5
Darkness 0 20 ± 0.5 0
Exophthalmia 0 0 0
V*
Fit rot 50 ± 0.5 50 ± 0.5 30 ± 0.5
Darkness 20 ± 0.5 10 ± 0.5 0
Exophthalmia 0 0 0
Control Fit rot 0 0 0
Darkness 0 0 0
Exop hthalmia 0 0 0
Note: BP (Boesenbergia pandurata), SF (Solanum ferox), ZZ (Zingiber zerumbet), and V (Vaccine Pseumulvacc)
 Table 2. Total bacteria in tilapia organ observation in day 14th after post challenge test with bacteria A. hydrophila 
and P. fluorescens
Group
Challenges time (CFU/mL)
Day-7 Day-14 Day-21
BP + V* 4.50 ± 0.1×104 2.00 ± 0.1×103 2.2 ± 0.1×103
SF + V* 11.3 ± 0.1×105 4.00 ± 0.1×105 4.4 ± 0.1×103
ZZ + V* 8.9 ± 0.1×104 4.3 ± 0.1×104 4.3 ± 0.1×104
ZZ+SF + V* 4.5 ± 0.1×104 2.1 ± 0.1×104 2.2 ± 0.1 ×103
V* 5.5 ± 0.1×105 3.3 ± 0.1×105 3.4 ± 0.1×104
Control 1.00×103 1.00×103 1.00×103
Note: BP (Boesenbergia pandurata), SF (Solanum ferox), ZZ (Zingiber zerumbet), and V (Vaccine Pseumulvacc)
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post-vaccination. The formalin killed whole-cells 
of S. agalactiae and A. hydrophila bivalent mixed 
vaccine given through intraperitoneal injection 
in tilapia, Oreochromis niloticus was able to 
improve specific fish immune system and increase 
the value of RPS post-challenge test with S. 
agalactiae and A. hydrophila, or coinfection with 
both S. agalactiae and A. hydrophila (Pasaribu et 
al., 2018) .
Antibody titers
This research used a simple method to 
examine the antibody titer;  Table 4 showed the 
result of value -log titer antibody. The results 
of measurement indicated that the value of fish 
antibody titer has already detected since 7 days 
after the test. However, the highest increase 
occurred on the 14th day of the 21st day test period 
increased up to 6 in the treatment using a mixture 
of B. pandurata as well as S. ferox and Z. zerumbet 
treatment, but the value was not significantly 
different between all treatments.
Phagocytic index (%)
The results showed the number of cells that 
performed phagocytosis in the mixing treatment 
between the vaccine and the extract increased 
post-challenge compared with the vaccine without 
extract (Table 5). The highest increase occurred in 
the treatment with the addition of S. ferox and Z. 
zerumbet. The phagocytic index increased on day 
14 and day 21.
Cumulative mortality and RPS
Tilapia test fish injected with bacteria A. hy-
drophila and P. fluorescens on day 7, 14 and 21-
post vaccination. Table 6 shows the cumulative 
mortality of tilapia. The entire tilapia fed with 
the mixture of extracts showed a decrease in the 
number of deaths compared to only vaccinated 
fish, ranging from seven days post-challenge test. 
When viewed from the post-challenge protective 
results, those seven days after the vaccination pe-
riod has given the protection to the fish, and the 
better the protection as the challenge time (14 
and 21 days post-vaccination) increases. Even 
Table 4. Tilapia’s antibody titers (-log2) at post-
vaccination observation in day 14th after post challenge 
with bacteria A. hydrophila and P. fluorescens
Group
Titer antibody challenges time
Day-7 Day-14 Day-21
BP + V* 4 5 6
SF + V* 3 4 5
ZZ + V* 3 5 5
ZZ+SF + V* 4 5 6
V* 0 4 5
Control 0 0 0
Note: BP (Boesenbergia pandurata), SF (Solanum 
ferox), ZZ (Zingiber zerumbet), and V (Vaccine 
Pseumulvacc)
Table 5. Phagocytic index (%) observation in day 14th 
after post challenge test with bacteria A. hydrophila 
and P. fluorescens 
Group
Phagocytic index (%) challenges 
time
Day-7 Day-14 Day-21
BP + V* 20.0 ± 0.5 60.2 ± 0.2 63.2 ± 0.6
SF + V* 22.2 ± 0.2 64.4 ± 0.2 62.2 ± 0.5
ZZ + V* 20.1 ± 0.1 64.4 ± 0.5 55.3 ± 0.7
ZZ+SF + V* 22.2 ± 0.3 55.3 ± 0.2 55.3 ± 0.1
V* 20.0 ± 0.1 50.2 ± 0.1 49.3 ± 0.2
Control 10.1± 0.2 11.2± 0.5 12.1± 0.3
Note: BP (Boesenbergia pandurata), SF (Solanum 
ferox), ZZ (Zingiber zerumbet), and V (Vaccine 
Pseumulvacc)
Table 6. Number of mortality and RPS of post-test indigo fish on day 7, 14 and 21 with bacteria A. hydrophila and 
P. fluorescens
Challenges time
Group Day-7 Day-14 Day-21
Mortality (%) RPS Mortality (%) RPS Mortality (%) RPS
BP + V* 10a 90cde 10a 91bcde 0abcd 100bcde
SF + V* 40bc 48b 40de 50a 0abcd 100bcde
ZZ + V* 30b 61bcd 20abc 72bc 0abcd 100bcde
ZZ+ SF + V* 40bcd 52bc 20abc 72bc 0abcd 100bcde
V* 50cde 28a 30bcd 77bcd 20abcde 80a
Note: BP (Boesenbergia pandurata), SF (Solanum ferox), ZZ (Zingiber zerumbet), and V (Vaccine Pseumulvacc). 
The same supercript letter indicated no significant difference (P>0.05).
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the vaccine-administered fish plus the B. pandu-
rata extract was able to provide 100% protection 
against fish post bacterial infections.
It seen from the RPS level, on the 7th day of 
the challenge test, the highest reached 90% in 
vaccine treatment plus the B. pandurata extract 
(P<0.05) (Table 6). It followed on the treatment 
of the 14th day tested vaccine with a B. pandu-
rata mixture was able to increase the best RPS 
reached 91%. However, in the 21st day of the 21st 
treatment, almost all vaccine treatments added 
with extracts were able to increase the RPS to 
100% better than only the treated vaccine with-
out the addition of extract (Table 6). The overall 
RPS results were significantly different from the 
non-extractive vaccine with P< 0.05. It turns out 
that the trial of using QSS as an adjuvant of the V. 
anguillarum vaccine in turbot fish indicating the 
same increasing in post-test RPS on days 14 and 
28 (Wang et al., 2016).
Discussion 
The utilization of adjuvant in vaccination to 
human (Pasquale et al., 2015; Wang et al., 2016) 
and fish (Bøgwald & Dalmo, 2012) has already 
done for a long time, as it proved to increase the 
immunogenicity of the vaccine. Some ingredi-
ents which known as an adjuvant were aluminum, 
water-in-oil emulsions (Freund›s adjuvants), part 
of microorganism cell and components of plant 
extracts (Rajput et al., 2007; Pasquale, 2015).
Plant extracts containing saponins, flavonoids, 
carbohydrates have the ability to immunomodu-
late fish such as B. pandurata, S. ferox and Z. 
zerumbet (Hardi et al., 2017a,b). Furthermore, 
Azadirachta indica extract, Ocimum sanctum, and 
Curcuma longa were able to increase the activity 
of phagocytosis, respiratory burst, and alterna-
tive complement activity and lysozyme goldfish 
(Carassius auratus) (Harikrishnan et al., 2009). 
Stratev et al. (2018) research showed that the 
treatment of fish pathogen infection using medici-
nal plants (secondary metabolites, fractions, or 
plant extracts) would be the best choice for sus-
tainable aquaculture.
There are many of the phytocomponents of 
plant extracts, one of them is saponin which al-
ready proven to boost the fish’s specific immune 
system when mixed with vaccines (Milgate & 
Roberts, 1995; Song & Hu, 2009; Bagherwal, 
2011). The saponin component of O. aponaria 
extract was able to prevent rotavirus infection by 
inhibiting viral attachment of host cells, through 
the destruction of cell membrane proteins virus 
receptors (Tam et al., 2011). Saponin also stimu-
lates growth and mucosal immune response that 
can prevent viral infections in humans (Wang et 
al., 2016; Tafalla et al., 2017). The results of the 
experiment by Wang et al. (2016) showed that uti-
lization of Q. saponaria saponin (QSS) (45 mg/L) 
mixed with Vibrio anguillarum formalin vaccine 
increased the antibody production of Scophthal-
mus maximus on the 28th day post vaccination. 
This indicated that QSS was capable as an adju-
vant vaccine through immersion. QSS was able 
to increase the effectiveness of immune cells by 
increasing complement activity and macrophage 
cell phagocytosis capable of consequent antigen 
presenting activity, thereby initiating the down-
stream humoral adaptive immune responses of 
the immunized fish.
The results also showed that the administra-
tion of B. pandurata extract was able to increase 
antibody titer production, in accordance with the 
increasing of post-trial RPS with combined bacte-
ria A. hydrophila and P. fluorescens extracts act as 
permeabilizing agents by which allowed the mol-
ecules penetrated into the cell, and have not been 
adequately addressed (Secombes & Belmonte, 
2016).
The addition of plant extracts increased the 
ability of antibodies to react with antigenic epi-
topes so that antigens were unable to recognize 
host cell receptors which would lead to failure of 
the antigen attachment process on the host cell 
surface (antibodies act as an inhibitor). In addi-
tion, the extract was also able to accelerate the 
elimination of antigen by the opsonizing process 
(antibody as opsonin). Formalin-killed E. tarda 
vaccine mixed with the Quil-A saponin increas-
ing the survival rates after E. tarda infection 
and showed better survival. Adjuvant utilization 
mix with the fish vaccine was strongly capable 
to induce a specific immune response and long 
duration time protection, therefore the impact 
increased the vaccine efficiency  (Tafalla et al., 
2013).
CONCLUSION
The conclusion of this research was the B. 
pandurata extract was a potential adjuvant in the 
application of vaccine in freshwater fish. It was 
shown by the RPS after challenges was signifi-
cantly higher than other treatment. The fish pro-
tection to bacterial infection was faster increase 
with B. pandurata administration (D7 and D14) 
than control (vaccine without extract).
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